Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-29

FDA Approved: LEVETIRACETAM — Supplemental Application (Granules Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for levetiracetam granules from Granules Pharmaceuticals Inc., adding a new formulation to the product's approved labeli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)